[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100281065":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":16,"locations":21,"responsibleParty":87,"collaborators":10,"id":89,"slug":90,"hasResults":91,"nctId":92,"briefTitle":93,"officialTitle":94,"acronym":95,"eligibilityCriteria":96,"healthyVolunteers":91,"sex":97,"minAge":10,"maxAge":10,"enrollmentInfo":98,"targetDuration":10,"studyType":101,"phases":10,"briefSummary":102,"conditions":103,"keywords":10,"overallStatus":24,"whyStopped":10,"lastUpdateSubmitDate":105,"lastUpdatePostDateStruct":106,"startDateStruct":109,"completionDateStruct":111,"leadSponsor":113,"locationsCount":114},{"fullName":5,"class":6},"Centre Hospitalier Universitaire de Nīmes","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"The study population",null,"Persons with stage \\>=4 chronic kidney disease.",[13],{"name":14,"affiliation":5,"role":15},"Olivier Moranne, MD, PhD","STUDY_DIRECTOR",[17],{"name":14,"role":18,"phone":19,"phoneExt":10,"email":20},"CONTACT","+33.(0)4.66.68.31.49","olivier.moranne@chu-nimes.fr",[22,44,59,76],{"facility":23,"status":24,"city":25,"state":10,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"AIDER - Unité de Dialyse d'Alès","RECRUITING","Alès","30100","France","FR",{"type":30,"coordinates":31},"Point",[32,33],4.08082,44.12489,{"lat":33,"lon":32},[36,39,42],{"name":37,"role":38,"phone":10,"phoneExt":10,"email":10},"Anne Wuillai, MD","PRINCIPAL_INVESTIGATOR",{"name":40,"role":41,"phone":10,"phoneExt":10,"email":10},"Médérick Mohajer, MD","SUB_INVESTIGATOR",{"name":43,"role":41,"phone":10,"phoneExt":10,"email":10},"Farid Bellahsene, MD",{"facility":45,"status":46,"city":47,"state":10,"zip":48,"country":27,"countryCode":28,"cosmosGeoPoint":49,"geoPoint":53,"contacts":54},"AIDER - Unité de Dialyse de Nîmes, CHU Carémeau","NOT_YET_RECRUITING","Nîmes","30029",{"type":30,"coordinates":50},[51,52],4.35788,43.83665,{"lat":52,"lon":51},[55,57],{"name":56,"role":38,"phone":10,"phoneExt":10,"email":10},"Laure Patrier, MD",{"name":58,"role":41,"phone":10,"phoneExt":10,"email":10},"Emilie Pambrun, MD",{"facility":60,"status":46,"city":47,"state":10,"zip":48,"country":27,"countryCode":28,"cosmosGeoPoint":61,"geoPoint":63,"contacts":64},"CHU de Nîmes - Hôpital Universitaire Carémeau",{"type":30,"coordinates":62},[51,52],{"lat":52,"lon":51},[65,66,68,70,72,74],{"name":14,"role":38,"phone":10,"phoneExt":10,"email":10},{"name":67,"role":41,"phone":10,"phoneExt":10,"email":10},"Pascal Reboul, MD",{"name":69,"role":41,"phone":10,"phoneExt":10,"email":10},"Sylvain Cariou, MD",{"name":71,"role":41,"phone":10,"phoneExt":10,"email":10},"Sophie Renaud, MD",{"name":73,"role":41,"phone":10,"phoneExt":10,"email":10},"Louis Marie Vernier, MD",{"name":75,"role":41,"phone":10,"phoneExt":10,"email":10},"Frédérique Vecina, MD",{"facility":77,"status":46,"city":47,"state":10,"zip":78,"country":27,"countryCode":28,"cosmosGeoPoint":79,"geoPoint":81,"contacts":82},"Gardialyse","30900",{"type":30,"coordinates":80},[51,52],{"lat":52,"lon":51},[83,85],{"name":84,"role":38,"phone":10,"phoneExt":10,"email":10},"Samir Boubenider, MD",{"name":86,"role":41,"phone":10,"phoneExt":10,"email":10},"Philippe Rousseau, MD",{"type":88,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100281065","feasibility-of-estimating-the-prevalence-and-management-of-stage-4-ckd-the-gard-france-100281065",false,"NCT02938611","Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France","Feasibility Study on Estimating the Prevalence and Management of Stage 4 Chronic Kidney Disease in Adults Via Laboratories and Nephrologists in the Gard, France","MRC-Gard","Inclusion Criteria:\n\n* chronic kidney disease (stage \\>= 4)\n\nExclusion Criteria:\n\n\\-","ALL",{"count":99,"type":100},3375,"ESTIMATED","OBSERVATIONAL","The main objective of this study is to evaluate the feasibility of estimating the prevalence of stage 4 and 5 chronic kidney disease in the Gard department of France from data obtained via laboratory databases. To verifiy if the demand for care thus authenticated by laboratory tests is adapted to nephrology care delivery, as recommended by the French High Authority of Health (HAS), laboratory data will be compared with those of patients seen by nephrologists in the department.",[104],"Renal Insufficiency, Chronic","2025-03-07",{"date":107,"type":108},"2025-03-10","ACTUAL",{"date":110,"type":108},"2019-01-01",{"date":112,"type":100},"2025-12",{"name":5,"class":6},4]